Current Affairs - National - Discussion
Discussion Forum : National - Latest Current Affairs (Q.No. 2760)
2760.
Biological E vaccine has received DGCI approval to conduct phase 2/3 trials on children. What is the name of its COVID vaccine candidate?
Answer: Option
Explanation:
Hyderabad-based Biological E Limited got approval from the Drug Controller General of India (DCGI) to conduct Phase 2 & 3 clinical trials for its COVID-19 vaccine Corbevax on children aged between 5 and 18 years of age with certain conditions.
Discussion:
Be the first person to comment on this question !
Post your comments here:
Quick links
Quantitative Aptitude
Verbal (English)
Reasoning
Programming
Interview
Placement Papers